Zdrowie i gospodarka · 04/09/2020

FDA Releases Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function

The FDA has released a draft guidance to help pharmaceutical companies design and analyze studies on how impaired renal function affects the efficacy and dosing of medications, replacing a previous version from 2010.